Korean J Gastroenterol.  2024 Jul;84(1):1-2. 10.4166/kjg.2024.066.

A New Korean Nomenclature for Steatotic Liver Disease

• Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)

• KMID: 2558282
• DOI: http://doi.org/10.4166/kjg.2024.066

Reference

1. Eslam M, Newsome PN, Sarin SK, et al. 2020; A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 73:202–209. DOI: 10.1016/j.jhep.2020.03.039. PMID: 32278004.

2. Eslam M, Sanyal AJ, George J. International Consensus Panel. 2020; MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 158:1999–2014.e1. DOI: 10.1053/j.gastro.2019.11.312. PMID: 32044314.

3. Eslam M, Sarin SK, Wong VW, et al. 2020; The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 14:889–919. DOI: 10.1007/s12072-020-10094-2. PMID: 33006093.

4. Rinella ME, Lazarus JV, Ratziu V, et al. 2023; A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 78:1966–1986. DOI: 10.1097/HEP.0000000000000520. PMID: 37363821. PMCID: PMC10653297.

5. Rinella ME, Lazarus JV, Ratziu V, et al. 2023; A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 79:1542–1556. DOI: 10.1016/j.jhep.2023.06.003. PMID: 37364790.

6. Kim GA, Moon JH, Kim W. 2023; Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clin Mol Hepatol. 29:831–843. DOI: 10.3350/cmh.2023.0277. PMID: 37634892. PMCID: PMC10577343.

7. Yoon EL, Jun DW. 2023; Waiting for the changes after the adoption of steatotic liver disease. Clin Mol Hepatol. 29:844–850. DOI: 10.3350/cmh.2023.0291. PMID: 37670441. PMCID: PMC10577335.

8. Kang SH, Lee HW, Yoo JJ, et al. 2021; KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 27:363–401. DOI: 10.3350/cmh.2021.0178. PMID: 34154309. PMCID: PMC8273632.

9. Gofton C, Upendran Y, Zheng MH, George J. 2023; MAFLD: How is it different from NAFLD? Clin Mol Hepatol. 29(Suppl):S17–S31. DOI: 10.3350/cmh.2022.0367. PMID: 36443926. PMCID: PMC10029949.

10. Cho JY, Sohn W. 2023; The growing burden of non-alcoholic fatty liver disease on mortality. Clin Mol Hepatol. 29:374–376. DOI: 10.3350/cmh.2023.0084. PMID: 36880212. PMCID: PMC10121311.